Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40187 |
GNF2133
|
DYRK | Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
GNF2133 是一种有效的特异性 DYRK1A 抑制剂,IC50 为 6.2 nM。 GNF2133 可用于关于 1 型糖尿病的研究。 | |||
T3074L |
CHIR98014 HCl (252935-94-7 free base)
CT-98014,CHIR-98014 hydrochloride,CHIR-98014,CHIR98014 HCl,CHIR98014,CHIR 98014 |
||
CHIR98014 is a reversible, cell-permeable inhibitor of GSK3α and GSK3β (IC50s: 0.65 and 0.58 nM). Through its effects on GSK3, CHIR98014 stimulates glycogen synthase in cells (EC50: 106 nM), potentiates insulin-dependent glucose transport in isolated musc | |||
T28511 |
Reglitazar
JTT-501,JTT501,PNU-182716,PNU182716,PNU-716 |
||
Reglitazar is a PPARɑ agonist and PPARγ agonist. Reglitazar rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle. Reglitazar improves insulin resistance in genetic and non-genetic insulin-resistant models. |